Peptide expert Helix BioMedix launches first finished product line

By Guy Montague-Jones

- Last updated on GMT

Related tags Helix biomedix Collagen

Bioactive peptide specialist Helix BioMedix has moved beyond the development of ingredients and brought out its own anti-aging line.

Striking Skin Care features a range of skin care products that all contain the SmartPeptide Heptapeptide-7, which is an anti-aging ingredient that helps nourish keratinocytes to support skin renewal.

Peptide behind the products

“Our SmartPeptides technology stimulates the skin’s own natural repair process and helps defend against environmental stress,”​ said R. Stephen Beatty, President and CEO of Helix BioMedix.

“Tests have shown that SmartPeptides boost collagen production and support the skin’s extracellular matrix, thereby reducing the appearance of fine lines and wrinkles while increasing the overall firmness of the skin.”

SmartPeptide Heptapeptide-7 is used exclusively in the Striking Skin Care line, which is comprised of Multi-Vitamin Creme Cleanser, Multi-Peptide Serum, Rejuvenating Eye Creme and Restorative Moisture Creme.

First finished product range

It is the first time Helix BioMedix has entered the market for finished products in skin care and cosmetics.

Explaining the move, Helix BioMedix vice president Robin Carmichael told “The range will provide an additional revenue source and an opportunity to market our technology and showcase our peptides.”

Targeted at women over the age of 50, the new products will be distributed by Orchard Brands, a company that brings in $1bn in revenue.

Targeting anti-ageing market

Helix BioMedix is targeting the anti-aging market having announced earlier this year the issue of a US patent for more than eighty peptides for use in cosmetics and in skin care.

Last September Helix BioMedix also signed a marketing agreement with the Evonik division of ingredients supplier Goldschmidt Personal Care.

Evonik has now launched its first Helix BioMedix peptide under the trade name Tego Pep 4-17 and is working on additional Helix BioMedix peptides through its own research and in collaboration with leading universities.

Related topics Market Trends

Related news

Show more